Exploring how EphB2 and NMDA receptors drive pain after cervical spinal cord injury
Official title: Exploring the EphB2-NMDA receptor interaction in spinal cord injury-induced neuropathic pain
Funded at Thomas Jefferson University · NIH-11371153 · Data updated 2026-11-12
This project looks at a specific molecular interaction in the spinal cord that may contribute to chronic pain after neck-level spinal cord injuries, with the goal of finding new ways to help patients who have neuropathic pain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2018 |
| Project end | June 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $603,149 |
| NIH project number | 5R01NS110385-08 |
| Project ID | NIH-11371153 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with cervical spinal cord injury who experience neuropathic pain may benefit from future therapies stemming from this research.
✕Less likely to help
People without neuropathic pain or those not involved in translational follow-up studies may not directly benefit.
What this research studies
Researchers will study how the EphB2 receptor interacts with NMDA receptors to change nerve signaling in the spinal cord after injury. The work uses animal models to understand how this interaction may make pain signals stronger and longer-lasting. By pinpointing the molecular steps that drive this pain, scientists hope to identify targets for therapies that could reduce neuropathic pain without relying on opioids. The project builds on prior findings that a single amino acid modification on EphB2 influences its interaction with NMDA receptors and pain-related signaling. This renewal aims to further define the mechanism and its role in cervical spinal cord injury–related pain, potentially guiding future translational efforts.
Why it matters
Potential benefit: If successful, the findings could lead to new non-opioid treatments that lessen chronic neuropathic pain after cervical spinal cord injury.
How similar studies have gone: Previous work shows EphB2–NMDA receptor interactions influence pain signaling, supporting potential for meaningful advances with this approach.
Where this research is happening
-
Thomas Jefferson University
Philadelphia, United States Active
Researchers
- Principal investigator: Lepore, Angelo C. — Thomas Jefferson University
- Study coordinator: Lepore, Angelo C.
Related research
Other NIH-funded projects on the same topics.
-
Diet and pain in Veterans with spinal cord injury
A study to see if better diet quality is linked to lower chronic neuropathic pain in veterans with spinal cord injury.
-
Gene therapy to relieve spinal cord injury-related neuropathic pain
This project tests a one-time gene therapy (6SHG/EM1) to reduce long-lasting neuropathic pain after spinal cord injury using a pig model to help move toward human treatment.
-
Breathing-controlled electrical stimulation device for neuropathic pain after spinal cord injury
A new, non-drug device aims to reduce neuropathic pain in people with spinal cord injuries using breathing-guided electrical stimulation.
-
Understanding Pain After Spinal Cord Injury
This project looks at how certain brain signals contribute to long-lasting pain after a spinal cord injury, hoping to find new ways to help patients.
-
A new device to help manage nerve pain after spinal cord injuries
This study is testing a new device called BreEStim that helps manage nerve pain for people with spinal cord injuries, offering a safe and drug-free way to find relief, and you can be part of this exciting research to help improve pain management!
-
Testing a new treatment for neuropathic pain after spinal cord injury in pigs
This study is exploring a new way to help people with nerve pain from spinal cord injuries by testing a special treatment in pigs that closely resemble human conditions, to see if it can effectively reduce their pain.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.